Investing.com – InMode Ltd. (NASDAQ:INMD) stock fell 4.7% in pre-market trading on Monday after the company announced the termination of a potential acquisition process.
The medical technology company stated that its independent trading committee concluded that the final proposals received were not sufficient and not in the best interests of the company and its shareholders. The committee, with the assistance of external financial and legal advisors, conducted a comprehensive review of all proposals.
InMode said the company will continue to review its business and growth strategies, as well as cash allocation strategies, with a focus on enhancing long-term shareholder value. The company does not plan to provide further updates on this matter unless necessary or required for additional disclosures.
This article was translated with the assistance of artificial intelligence. For more information, please see our Terms of Use.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
InMode stock price drops due to termination of acquisition process
Investing.com – InMode Ltd. (NASDAQ:INMD) stock fell 4.7% in pre-market trading on Monday after the company announced the termination of a potential acquisition process.
The medical technology company stated that its independent trading committee concluded that the final proposals received were not sufficient and not in the best interests of the company and its shareholders. The committee, with the assistance of external financial and legal advisors, conducted a comprehensive review of all proposals.
InMode said the company will continue to review its business and growth strategies, as well as cash allocation strategies, with a focus on enhancing long-term shareholder value. The company does not plan to provide further updates on this matter unless necessary or required for additional disclosures.
This article was translated with the assistance of artificial intelligence. For more information, please see our Terms of Use.